{"slideshow_credits": null, "snippet": "The diligence of the board of Alere, a diagnostic tester, brought a chunky 51 percent premium in the $5.8 billion sale to Abbott, announced on Monday.", "abstract": null, "section_name": "Business Day", "print_page": null, "document_type": "article", "byline": {"person": [{"firstname": "Robert", "role": "reported", "lastname": "CYRAN", "rank": 1, "organization": ""}], "original": "By ROBERT CYRAN"}, "web_url": "http://www.nytimes.com/2016/02/02/business/dealbook/strategy-of-alere-board-paid-off-with-buyout-by-abbott.html", "lead_paragraph": "The diligence of the board of Alere, a diagnostic tester, brought a chunky 51 percent premium in the $5.8 billion sale to Abbott, announced on Monday.", "headline": {"main": "Strategy of Alere Board Paid Off With Buyout by Abbott", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "_id": "56af9db138f0d8491255922f", "word_count": "345", "multimedia": [], "pub_date": "2016-02-02T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1"}, {"name": "organizations", "value": "Abbott Laboratories", "is_major": "N", "rank": "2"}, {"name": "organizations", "value": "Alere Inc", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}